C. M. Ballantyne Et Al. , "A Multiregional, Randomized Evaluation of the Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients With Hypercholesterolemia or Low High-Density Lipoprotein Cholesterol," AMERICAN JOURNAL OF CARDIOLOGY , vol.120, no.4, pp.569-576, 2017
Ballantyne, C. M. Et Al. 2017. A Multiregional, Randomized Evaluation of the Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients With Hypercholesterolemia or Low High-Density Lipoprotein Cholesterol. AMERICAN JOURNAL OF CARDIOLOGY , vol.120, no.4 , 569-576.
Ballantyne, C. M., Shah, S., Sapre, A., Ashraf, T. B., Tobias, S. C., ŞAHİN, T., ... Ye, P.(2017). A Multiregional, Randomized Evaluation of the Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients With Hypercholesterolemia or Low High-Density Lipoprotein Cholesterol. AMERICAN JOURNAL OF CARDIOLOGY , vol.120, no.4, 569-576.
Ballantyne, Christie Et Al. "A Multiregional, Randomized Evaluation of the Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients With Hypercholesterolemia or Low High-Density Lipoprotein Cholesterol," AMERICAN JOURNAL OF CARDIOLOGY , vol.120, no.4, 569-576, 2017
Ballantyne, Christie M. Et Al. "A Multiregional, Randomized Evaluation of the Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients With Hypercholesterolemia or Low High-Density Lipoprotein Cholesterol." AMERICAN JOURNAL OF CARDIOLOGY , vol.120, no.4, pp.569-576, 2017
Ballantyne, C. M. Et Al. (2017) . "A Multiregional, Randomized Evaluation of the Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients With Hypercholesterolemia or Low High-Density Lipoprotein Cholesterol." AMERICAN JOURNAL OF CARDIOLOGY , vol.120, no.4, pp.569-576.
@article{article, author={Christie M. Ballantyne Et Al. }, title={A Multiregional, Randomized Evaluation of the Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients With Hypercholesterolemia or Low High-Density Lipoprotein Cholesterol}, journal={AMERICAN JOURNAL OF CARDIOLOGY}, year=2017, pages={569-576} }